Related Experiment Videos
Evaluation of Salmonella porins as a broad spectrum vaccine candidate
B Tabaraie1, B K Sharma, P R Sharma
1Department of Experimental Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Abstract:
Porins were prepared from smooth strain of Salmonella typhi 0-901 and chemotype of rough mutant of S. typhimurium Ra-30. Mice were immunized with both the porin preparations in different groups and challenged with S. typhimurium LT2-71 and S. enteritidis SH-1269. Porin immunized mice showed significant protection (P < 0.01) against challenge with homologous as well as heterologous strains. Hence, the use of porins may be attempted in future to protect against salmonellosis.
Insights
Salmonella porins offer significant protection against homologous and heterologous strains in mice. This suggests porins could be a future strategy for preventing salmonellosis.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Salmonellosis remains a significant public health concern.
- Porins are outer membrane proteins of Gram-negative bacteria, including Salmonella.
- Developing effective vaccines against Salmonella is crucial for disease prevention.
Purpose of the Study:
- To evaluate the protective efficacy of Salmonella porins against homologous and heterologous strains.
- To assess the potential of porin-based immunization for preventing salmonellosis.
Main Methods:
- Porins were isolated from Salmonella typhi and a rough mutant of S. typhimurium.
- Mice were immunized with these porin preparations.
- Immunized mice were challenged with virulent strains of S. typhimurium and S. enteritidis.
Main Results:
- Porin immunization conferred significant protection (P < 0.01) in mice.
- Protection was observed against both homologous (S. typhimurium) and heterologous (S. enteritidis) challenge strains.
- The results indicate a broad protective immune response induced by the porin preparations.
Conclusions:
- Salmonella porins demonstrate potential as vaccine candidates against salmonellosis.
- Porin-based vaccines may offer cross-protection against different Salmonella serovars.
- Further investigation into porin use for salmonellosis prevention is warranted.